We are live on
!
Find out more
VEA
Virtus ETF Advisers Portfolio holdings
AUM
$215M
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+0.15%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$474M
AUM Growth
+$427M
(+909%)
Cap. Flow
+$433M
Cap. Flow
% of AUM
91.18%
Top 10 Holdings %
Top 10 Hldgs %
10.55%
Holding
454
New
296
Increased
64
Reduced
55
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
OXLC
Oxford Lane Capital
OXLC
|
+$6.86M |
| 2 |
Barings BDC
BBDC
|
+$6.33M |
| 3 |
Oxford Square Capital
OXSQ
|
+$5.45M |
| 4 |
ECC
Eagle Point Credit Company
ECC
|
+$5.29M |
| 5 |
FS KKR Capital
FSK
|
+$5.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$2.25M |
| 2 |
ACOR
Acorda Therapeutics
ACOR
|
+$644K |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
+$605K |
| 4 |
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
|
+$603K |
| 5 |
uniQure
QURE
|
+$374K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.58% |
| 2 | Real Estate | 14.99% |
| 3 | Energy | 13.55% |
| 4 | Healthcare | 12.23% |
| 5 | Materials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
NextEra Energy
NEE
$187B
| $23K | ﹤0.01% |
452
-112
| -20% | -$5.51K |
|
352
NetEase
NTES
$76.5B
| $23K | ﹤0.01% |
455
-5
| -1% | -$265 |
|
|
BNY
353
Bank of New York Mellon
BNY
$108B
| $22K | ﹤0.01% |
+495
| New | +$23.3K |
|
354
Church & Dwight Co
CHD
$23.1B
| $22K | ﹤0.01% |
+302
| New | +$22.5K |
|
355
General Mills
GIS
$19.2B
| $22K | ﹤0.01% |
+426
| New | +$22K |
|
356
NXP Semiconductors
NXPI
$68B
| $22K | ﹤0.01% |
227
+75
| +49% | +$7.27K |
|
357
Pfizer
PFE
$140B
| $22K | ﹤0.01% |
+532
| New | +$21.1K |
|
358
Synchrony
SYF
$23.7B
| $22K | ﹤0.01% |
644
| – | – |
|
359
Allstate
ALL
$66.9B
| $21K | ﹤0.01% |
+204
| New | +$19.9K |
|
360
Baidu
BIDU
$35.8B
| $21K | ﹤0.01% |
+177
| New | +$25.2K |
|
361
Darden Restaurants
DRI
$22.5B
| $21K | ﹤0.01% |
+172
| New | +$20.5K |
|
362
PayPal
PYPL
$49.5B
| $21K | ﹤0.01% |
+184
| New | +$20.4K |
|
363
Waste Management
WM
$95.9B
| $21K | ﹤0.01% |
181
| – | – |
|
364
Ambev
ABEV
$47.3B
| $20K | ﹤0.01% |
4,305
-3,049
| -41% | -$13.7K |
|
365
Fortinet
FTNT
$112B
| $20K | ﹤0.01% |
+1,305
| New | +$21.5K |
|
366
PepsiCo
PEP
$186B
| $20K | ﹤0.01% |
+154
| New | +$19.7K |
|
367
WEC Energy
WEC
$37.7B
| $20K | ﹤0.01% |
240
-211
| -47% | -$16.9K |
|
368
Equity Residential
EQR
$25.4B
| $19K | ﹤0.01% |
253
-118
| -32% | -$9.01K |
|
369
Public Storage
PSA
$60.2B
| $19K | ﹤0.01% |
80
-22
| -22% | -$5.05K |
|
370
Voya Financial
VOYA
$8.94B
| $19K | ﹤0.01% |
+348
| New | +$18.6K |
|
|
ETFC
371
DELISTED
E*Trade Financial Corporation
ETFC
| $19K | ﹤0.01% |
+430
| New | +$20.5K |
|
372
AngloGold Ashanti
AU
$40.3B
| $18K | ﹤0.01% |
+1,032
| New | +$13.9K |
|
373
Everest Group
EG
$15.2B
| $18K | ﹤0.01% |
72
| – | – |
|
374
HCA Healthcare
HCA
$84.8B
| $18K | ﹤0.01% |
+135
| New | +$17.1K |
|
375
OGE Energy
OGE
$10.3B
| $18K | ﹤0.01% |
+415
| New | +$17.6K |
|
Similar funds
NCM
SSA
LIWM
VFG
IAM
1M
GC
ALS
Virtus ETF Advisers's Q2 2019 Portfolio in Review
As of Q2 2019, Virtus ETF Advisers held 454 positions worth $474M, up 909% from $47M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Virtus ETF Advisers deployed $433M of net new capital in Q2 2019, opening 296 new positions and adding to 64 existing holdings. Its largest new stake was Oxford Lane Capital: 132,284 shares worth $6.67M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 0.73% a quarter earlier, followed by Real Estate and Energy.
On the sell side, the largest reduction was Array Biopharma Inc, an estimated $605K trimmed.
- Virtus ETF Advisers's largest Q2 2019 buy was Oxford Lane Capital: 132,284 shares worth $6.67M.
- Virtus ETF Advisers added most to Dominion Energy in Q2 2019, an estimated $2.63M increase.
- Virtus ETF Advisers's biggest Q2 2019 reduction was Array Biopharma Inc, cutting an estimated $605K.
- Virtus ETF Advisers fully exited Spark Therapeutics, Inc. Common Stock in Q2 2019, selling an estimated $2.25M.
- Virtus ETF Advisers's ten largest holdings make up 11% of its $474M portfolio in Q2 2019.
- Virtus ETF Advisers opened 296 new positions and closed 20 in Q2 2019.
- Virtus ETF Advisers's portfolio value rose 909% quarter-over-quarter to $474M.
Based on Virtus ETF Advisers's 13F filing for Q2 2019, filed 13 Aug 2019.